Effect of pioglitazone and empagliflozin on glycemic control and TyG index
Triglyceride-glucose, fatty liver, NAFLD fibrosis, high-density lipoprotein, Liver stiffness
FATTY LIVER, INSULIN RESISTANCE
Changes in BMI, FBS, HbA1c, Total cholesterol, LDL, HDL, AST, ALT, and TyG index from baseline are shown in Table 
Anthropometric and Biochemical Characteristics of the participants at Baseline and by week 24ALT, alanine aminotransferase; AST, aspartate transaminase; BMI, body mass index; CAP, controlled attenuation parameter; FBS, fasting blood sugar; FIB4 index, fibrosis-index; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; LSM, Liver stiffness measurement; NAFLD fibrosis score, non-alcoholoic fatty liver score; Tchol, total Cholesterol; TG, Triglycerides* Triglyceride-glucose index (TyG) = Ln [FBS (mg/dl) × TG (mg/dl)/2]TyG index has been proposed as a numerical expression of insulin resistance (IR)**P value < 0.05 is considered as significant.*Between-group difference from the baseline, P value < 0.05 is considered as significant.